Graham G. Walmsley's Form 4/A amendment
AmendedOlema Pharmaceuticals, Inc. (OLMA) · filed Nov 26, 2024
- Accession no.
- 0000935836-24-000744
- Filed
- Nov 26, 2024
- Trade date
- Jun 4, 2024
- Filing delay
- 175 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jun 6, 2024
This filing lists 2 non-derivative transactions. Open-market sales total $17.4M. It was filed 175 days after the trade.
This amendment replaces 0000935836-24-000425 (filed Jun 6, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Graham G. WalmsleyCIK 0001777517 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | Common Stock | SSaleDisposed | −700,000 | $14.85 | −$10,395,000 | 700,761 | Indirect | |
| Jun 4, 2024 | Common Stock | SSaleDisposed | −475,000 | $14.85 | −$7,053,750 | 708,114 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- F2
The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Remarks
On June 6, 2024, the reporting person filed a Form 4 which inadvertently reported the date of the earliest transaction required to be reported as September 12, 2023. The earliest transaction required to be reported was June 4, 2024. The reporting person is filing this amendment to correct that date. None of the other information in the Form 4 is being changed by this amendment.